Background Increased levels of thyroglobulin (Tg) and thyroid-stimulating hormone (TSH)
are associated with differentiated thyroid carcinoma (TC) risk, but strong epidemiological …

110001, PR China 2) Department of Endocrinology and Metabolism, The Endocrine Institute
and The Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Hospital of …

Differentiated thyroid cancer is the most common endocrine malignancy and the incidence is
increasing rapidly worldwide. Appropriate diagnosis and post-treatment monitoring of …

There is mounting evidence that the serum concentration of TSH is an independent predictor
for the diagnosis of thyroid malignancy in patients with nodular thyroid disease. Furthermore …

Background: The effects of thyroid-stimulating hormone (TSH) and thyroid hormones on the
development of human papillary thyroid cancer (PTC) remain poorly understood. Methods …

Context: TSH is the major growth factor for thyrocytes and may have a causative role in
thyroid cancer. Objective: The objective of the study was to systematically assess the …

Background A remarkable increase in the number of thyroid cancer cases has been
reported in recent years; however, the markers to predict high-risk groups have not been …

Context: TSH is a known thyroid growth factor, but the pathogenic role of TSH in thyroid
oncogenesis is unclear. Objective: The aim was to examine the relationship between …

Background: Serum thyrotropin (TSH) concentration and thyroid autoimmunity may be of
prognostic importance in differentiated thyroid cancer (DTC). Preoperative serum TSH level …

Objectives Higher thyroid‐stimulating hormone (TSH) levels are associated with
differentiated thyroid cancers (DTC). To validate this association, we compared TSH levels …